1.                   Welcome & Apologies 

Apologies were received from Alastair Kent, Imran Rafi, Hilary Burton 

2.                   BSHG Affiliation 

BSHG has ratified SGPPH’s affiliation at its AGM at the end of August.  Affiliation will take effect in April 2010.  AH to meet Ruth Cole to progress this issue.  Action: AH

It was previously decided that in April 2010 BSHG will collect £55 from the SGPPH members who are also members of BSHG and £15 from the non-members.  From April 2011 all SGPPH members will pay the BSHG membership fee of £55.  However the meeting decided to raise the non-members membership fee for 2010 – 2011 to £20.  Action: JL

A person is needed to represent SGPPH on the BSHG Council now.  It was agreed that LJ would do this.  Action: LJ 3.                  

SGPPH Events 

i)    BSHG Plenary:  AH reported that this had gone very well.  The reduced audience numbers may have been due to the timing of the session at lunchtime – to be avoided in future.    
  
ii)    ESHG Conference – 7/8 OctoberU SGPPH has been given a plenary session at this conference.  AH is speaking, LJ will chair.  AH to send LJ her powerpoint for further discussions.  Action: AH.  AH to take AGM flyers, general SGPPH flyers and the BSHG poster with her to this event.  Action: AH

iii)   4^th AGM Update
AH reported that 6 speakers have been booked, and that delegate numbers were rising in a satisfactory fashion.

IR has resigned as a council member but no replacement has been found to date. AH to ask him for ideas in the GP community for a replacement.  Action: AH   Alison Harvey was in touch with a lady who may be interested in taking the secretary’s post.  She will let us know next week.  If she accepts the role then she may need to shadow AH for a period leading up to the AGM and attend the latter, in order to learn about what the job entails.  Action: AHar and AH 

iv)   Spring Meeting 2010
Various possible topics were discussed.  This included individualised/personalised medicine, direct to consumer medicine issues and new breaking science with its implications for policy and direct to consumer medicine.  Regarding the 3^rd topic: DM described how this could include gene expression and epigenetic arrays, and could be included as part of a meeting on personalised medicine.

DM, MH and hopefully the new secretary would form the subcommittee.

Once the situation over the replacement secretary was known, AH would have an email discussion with the council members to finalise the chosen topic for this meeting.  Action: AH

4.         AOB 

Name change and logo: MH would now take the lead on this issue.  LJ would send her work on the subject to date to him by email.  He would then commence further email discussions with the council about this issue.  It was considered that the name needed to include the words ‘genomics’ and ‘policy’.  Action: MH

JL would birdcage the council about a date for the next council meeting in December.  Action: JL